Form 4 holding
VP, Finance and Accounting
LEXICON PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 76,368
- Estimated value
- $51,167
- Report date
- 28 Feb 2025
- Price
- $0.6700
- Ownership
- Direct
Kristen L. Alexander - VP, Finance and Accounting at LEXICON PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- VP, Finance and Accounting
- Issuer ticker
- LXRX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Kristen L. Alexander since 15 Aug 2025
Reported holdings for Kristen L. Alexander in LEXICON PHARMACEUTICALS, INC.
Form 4 holding
VP, Finance and Accounting
LEXICON PHARMACEUTICALS, INC.
- Security class
- Restricted Stock Units
- Shares / value
- 39,773
- Estimated value
- $26,648
- Report date
- 28 Feb 2025
- Price
- $0.6700
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
VP, Finance and Accounting
LEXICON PHARMACEUTICALS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 185,540
- Estimated value
- Report date
- 13 Feb 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Kristen L. Alexander in LEXICON PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.